[{"NetIncomeLoss_1_Q3_USD":-20270000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"AccruedLiabilitiesCurrent_0_Q3_USD":7472000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":113000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":37061000.0,"Depreciation_3_Q3_USD":713000.0,"Depreciation_1_Q3_USD":200000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":837575.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":3261000.0,"AssetsCurrent_0_Q3_USD":184652000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_3_Q3_USD":163747000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":2949399.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":3172000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_3_Q3_USD":211602000.0,"CommonStockSharesIssued_0_Q3_shares":24261412.0,"Assets_0_Q3_USD":211717000.0,"ShareBasedCompensation_3_Q3_USD":5872000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":12232000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q3_shares":6595779.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3_Q3_USD":19.9,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.01,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.01,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":1138000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":3008000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":30646729.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":-2221000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":30563614.0,"GeneralAndAdministrativeExpense_3_Q3_USD":13110000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":45431000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":15829000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":14.6,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":14018000.0,"InvestmentsAndCash_0_Q3_USD":180200000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":4016000.0,"ProceedsFromStockPlans_3_Q3_USD":317000.0,"CommonStockValue_0_Q3_USD":243000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":-1129000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-56663000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-20453000.0,"AccruedEmployeeBenefitsCurrent_0_Q3_USD":3793000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":-266000.0,"OtherAssetsNoncurrent_0_Q3_USD":486000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":27284000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":10259000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":351694000.0,"Liabilities_0_Q3_USD":23541000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":70000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-183000.0,"OperatingLeaseLiability_0_Q3_USD":12880000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q3_USD":4.88,"GeneralAndAdministrativeExpense_1_Q3_USD":4732000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":758000.0,"CommonStockSharesAuthorized_0_Q3_shares":1000000000.0,"OperatingIncomeLoss_1_Q3_USD":-20561000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":1977000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3_Q3_USD":1493000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":2593000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-44539000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":3086000.0,"LiabilitiesCurrent_0_Q3_USD":13282000.0,"AccountsPayableCurrent_0_Q3_USD":3189000.0,"NonoperatingIncomeExpense_3_Q3_USD":1808000.0,"NonoperatingIncomeExpense_1_Q3_USD":291000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":4416000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":47000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":54000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.038,"IncreaseDecreaseInOtherOperatingAssets_3_Q3_USD":228000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q3_USD":27284000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":149609.0,"OperatingLeasePayments_3_Q3_USD":2245000.0,"OperatingLeasePayments_1_Q3_USD":755000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":1346000.0,"DividendsCommonStock_3_Q3_USD":0.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":14347000.0,"NetIncomeLoss_3_Q3_USD":-56733000.0,"CommonStockSharesOutstanding_0_Q3_shares":24261412.0,"OperatingIncomeLoss_3_Q3_USD":-58541000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-8607000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q3_shares":1335607.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q3_USD":152952000.0,"IncreaseDecreaseInIncomeTaxesReceivable_3_Q3_USD":-35000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":43.17,"PreferredStockValue_0_Q3_USD":null,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":1.32,"OperatingLeaseCost_3_Q3_USD":2301000.0,"OperatingLeaseCost_1_Q3_USD":767000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":211717000.0,"PreferredStockSharesAuthorized_0_Q3_shares":200000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3_Q3_shares":34332.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":16324000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":2621000.0,"OperatingExpenses_3_Q3_USD":58541000.0,"OperatingExpenses_1_Q3_USD":20561000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-1.86,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.66,"ProfitLoss_3_Q3_USD":-56733000.0,"StockholdersEquity_0_Q3_USD":188176000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":10794000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":227000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":2942843.0,"VariableLeaseCost_3_Q3_USD":171000.0,"VariableLeaseCost_1_Q3_USD":57000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-163938000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":333000.0,"Ticker":"IGMS","CIK":"1496323","name":"IGM BIOSCIENCES, INC.","OfficialName":"IGM Biosciences Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"806397058.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201105"}]